For several years, Express Scripts has been offering what it calls Care Value programs for certain disease states with specialty-drug therapies, ranging from diabetes to multiple sclerosis (there are 10 such programs, including oncology). Now, it is adding a Rare […]
Read More
Most of the US is still waiting for the Trump Administration to follow through on its ambitious goals for confronting opioid abuse; in the meantime, efforts from private industry and advocacy groups are proliferating. The Healthcare Distribution Alliance has joined […]
Read MoreWith the US and EU about to implement the next stage of their ‘track and trace’ legislation to combat illegal drugs in the pharmaceutical supply chain. Whether illegally diverted from the supply chain through theft or introduced into the supply […]
Read MoreYou shouldn’t have to defend the inadequacies of your hub. BioSolutia is making its mark as the leader in customized solutions, based on the specific needs of the drug, medical device, technology and manufacturer client. BioSolutia is NOT your big […]
Read More
On the eve of the Am. Soc. of Clinical Oncologists meeting (June 1-5, Chicago), IQVIA has released its annual review of drug development and spending in oncology, Global Oncology Trends 2018. The topline finding is that global spending (therapeutic and […]
Read MoreA data warehouse is commonly understood to be a way to store structured data—for example, sales reports—in a way that makes retrieval or performing analytics faster and easier. Inevitably, once a warehouse is built, some other department or business function […]
Read MoreLate spring is a busy time on the annual conference circuit, as academics wind down the spring semester, and trade and professional organizations are able to do a mid-year review and forward-looking forecast of their field. So is the case […]
Read MoreThe delay between when a medication is prescribed and when the patient can receive the prescription is a critical issue in patient care, particularly for specialty pharmaceuticals whose reimbursement can be a challenging hurdle. Many patient-support (hub) service providers, including […]
Read MoreIf this were a dispute between statisticians at FDA and elsewhere over, say, sodium bicarbonate consumption, it would probably barely be noticed. But since it involves opioids—and fentanyl, specifically—FDA chose to issue a public statement challenging IQVIA’s recent reporting of […]
Read MoreThe new cellular and genetic therapies (CGTs) to win FDA approval are likely to be the first tumbling rocks of what will become a landslide of new therapies, especially those employing technologies like the CAR-T method. Gilead Sciences ponied up […]
Read More